Kodak Turns to Drug Production to Fight COVID-19

Former American photography firm Kodak began making drug ingredients four years ago and will now dramatically expand production at its New York and Minnesota facilities.

The fallen giant of the photography industry will make ingredients used in generic drugs to help fight the coronavirus.

The Eastman Kodak Company was founded by George Eastman in 1888. The company became famous for its “Kodak moment” tagline but began to struggle financially in the late 1990s as consumers moved away from photographic film and towards digital photography.

At its peak, Kodak employed more than 145,000 people worldwide but now has a global workforce of around 5,000.

In 2012, Kodak filed for Chapter 11 bankruptcy protection in the United States and shifted its focus to printing and professional services for companies. But it does still make digital and instant cameras for consumers.

Another photography firm, Japan’s Fujifilm, made its pivot years ago and is now working on a potential Covid-19 vaccine. It hopes to start human trials soon.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.